Medico Remedies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medico Remedies Limited has submitted its financial results for the quarter and half-year ended September 30, 2025 to NSE. The filing covers Q2 FY2026 and H1 FY2026 results, which typically include revenue, expenses, profit before tax, profit after tax, and EPS details. Specific numbers from the actual results document are not included in this notice — investors should refer to the detailed results PDF filed alongside this submission for the complete figures.
This is a routine compliance filing confirming that the company has met its quarterly disclosure obligation. Actual stock or shareholder impact will depend on the underlying numbers in the detailed results, which are not available in this notice.